Farnaz Memarzadeh, MD, describes anti-VEGF therapy in glaucoma in an interview with Dr. Brian Francis at the 2008 AAO meeting in Atlanta. Dr. Memarzadeh reviews some of the indications where anti-VEGF therapy may be used: neovascular glaucoma (NVG),…
Dr. Uday Devgan Shares Pearls for MICS and the Management of Sub-optimal Surgical Outcomes
Uday Devgan, MD shares pearls for converting to microincisional phacoemulsification in an interview with Dr. David Goldman. Microincisional cataract surgery (MICS) is becoming very popular and may soon become the predominant method for performing this…
Albert J. Augustin, MD, On Combination Therapy Against Choroidal Neovascularization (CNV)
Dr. Albert J. Augustin from the University of Mainz in Germany discusses treatment strategies against choroidal neovascularization (CNV) in a conversation with retina specialist, Dr. Sophie Bakri. Dr. Augustine defines the combination therapy paramete…
Video: AAO 2008 Meeting Highlights from Audrey Talley-Rostov, MD
Featured Article
AAO 2008: Bradley Randleman, MD, Describes A New Ectasia Risk Assessment Model
Dr. J. Bradley Randleman discusses a new risk-score model for assessing post-LASIK ectasia risk in an interview with refractive editor Dr. David Goldman. Five risk factors were identified: 1.) topographic abnormalities, 2.) low residual stromal bed t…
Management of IFIS (Intraoperative Floppy Iris Syndrome)
Technology Spotlight